Biocardia Stock In The News
| BCDA Stock | USD 2.28 0.09 3.80% |
Our overall analysis of Biocardia's news coverage and content from conventional and social sources shows investors' bearish mood towards Biocardia. The specific impact of Biocardia news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Biocardia's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Biocardia headlines in addition to utilizing other, more conventional financial analysis modules. Check out Biocardia Backtesting and Biocardia Hype Analysis. For information on how to trade Biocardia Stock refer to our How to Trade Biocardia Stock guide.
Biocardia |
Biocardia Today Top News and Investor Outlook
Biocardia Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Biocardia and other traded companies coverage with news coverage. We help investors stay connected with Biocardia headlines for the 26th of November to make an informed investment decision based on correlating the impacts of news items on Biocardia Stock performance. Please note that trading solely based on the Biocardia hype is not for everyone as timely availability and quick action are needed to avoid losses.
Biocardia stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Biocardia earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Biocardia that are available to investors today. That information is available publicly through Biocardia media outlets and privately through word of mouth or via Biocardia internal channels. However, regardless of the origin, that massive amount of Biocardia data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biocardia news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biocardia relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biocardia's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biocardia alpha.
Biocardia Largest EPS Surprises
Earnings surprises can significantly impact Biocardia's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-03-27 | 2023-12-31 | -0.11 | -0.09 | 0.02 | 18 | ||
2023-03-29 | 2022-12-31 | -0.18 | -0.16 | 0.02 | 11 | ||
2022-05-11 | 2022-03-31 | -0.24 | -0.2 | 0.04 | 16 | ||
2021-11-10 | 2021-09-30 | -0.21 | -0.16 | 0.05 | 23 | ||
2022-11-09 | 2022-09-30 | -0.23 | -0.17 | 0.06 | 26 | ||
2021-05-13 | 2021-03-31 | -0.24 | -0.18 | 0.06 | 25 |
Biocardia Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Biocardia Stock. Current markets are strongly bearish. About 75% of major world exchanges and indexes are down. See today's market update for more information.
19th of November 2024
Biocardia CEO Peter Altman acquires 2,524 in common stock at investing.com
15th of November 2024
BioCardia, Inc. Q3 2024 Earnings Call Transcript at insidermonkey.com
13th of November 2024
BioCardia Reports Third Quarter 2024 Business Highlights and Financial Results at finance.yahoo.com
6th of November 2024
Urogen Pharma Reports Q3 Loss, Tops Revenue Estimates at zacks.com
28th of October 2024
BioCardia Completes Phase III Randomized Double-Blind Controlled Trialof Autologous Cell T... at globenewswire.com
15th of October 2024
Short Interest in BioCardia, Inc. Decreases By 12.6 at thelincolnianonline.com
30th of September 2024
Acquisition by Allen Jim L. of 50000 shares of Biocardia at 3.0 subject to Rule 16b-3 at MacroaxisInsider
25th of September 2024
Acquisition by Allen Jim L. of 50000 shares of Biocardia at 3.0 subject to Rule 16b-3 at MacroaxisInsider
19th of September 2024
Acquisition by Allen Jim L. of 50000 shares of Biocardia at 3.0 subject to Rule 16b-3 at MacroaxisInsider
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biocardia in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biocardia's short interest history, or implied volatility extrapolated from Biocardia options trading.
Check out Biocardia Backtesting and Biocardia Hype Analysis. For information on how to trade Biocardia Stock refer to our How to Trade Biocardia Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biocardia. If investors know Biocardia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biocardia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.03) | Revenue Per Share 0.264 | Quarterly Revenue Growth (0.93) | Return On Assets (1.16) | Return On Equity (7.04) |
The market value of Biocardia is measured differently than its book value, which is the value of Biocardia that is recorded on the company's balance sheet. Investors also form their own opinion of Biocardia's value that differs from its market value or its book value, called intrinsic value, which is Biocardia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biocardia's market value can be influenced by many factors that don't directly affect Biocardia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biocardia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biocardia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biocardia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.